{"success":true,"data":{"pressRelease":{"id":"105431","rtpr_id":"nBw13WTnya","ticker":"RVTY","exchange":"NYSE","all_tickers":["RVTY"],"title":"Revvity Board Declares Quarterly Dividend","author":"Business Wire","published_at":"2026-07-31T20:05:00.194Z","article_body":"Revvity Board Declares Quarterly Dividend\n\nThe Board of Directors of Revvity, Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.revvity.com%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Revvity%2C+Inc.&index=1&md5=fe0d6c75dfcd2999a171b009d1893cf1)\n(NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share\nof common stock. This dividend is payable on November 13, 2026 to all\nshareholders of record at the close of business on October 23, 2026.\n\nAbout Revvity\n\nAt Revvity, “impossible” is inspiration, and “can’t be done” is a\ncall to action. Revvity provides health science solutions, technologies,\nexpertise and services that deliver complete workflows from discovery to\ndevelopment, and diagnosis to cure. Revvity is revolutionizing what’s\npossible in healthcare, with specialized focus areas in translational\nmulti-omics technologies, biomarker identification, imaging, prediction,\nscreening, detection and diagnosis, informatics and more.\n\nWith 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity\nserves customers across pharmaceutical and biotech, diagnostic labs, academia\nand governments. It is part of the S&P 500 index and has customers in more\nthan 160 countries.\n\nStay updated by following our Newsroom\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnews.revvity.com%2Foverview%2Fdefault.aspx&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Newsroom&index=2&md5=7a20070ef771ef421fa2501cfb6416af)\n, LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Frevvity%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=LinkedIn&index=3&md5=aeec4cf587893654c63524eab42bb246)\n, X\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2FRevvityInc&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=X&index=4&md5=e85a0ef6ec61eb426d884ffd880804fd)\n, YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCUqLrqOpUUwhz3UaLn78tVQ&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=YouTube&index=5&md5=bf0ff09de6e49412084b81abee1d414d)\n, Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FRevvityInc&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Facebook&index=6&md5=6f9e393ecf03b48a979732f8bf837258)\nand Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Frevvity%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Instagram&index=7&md5=e064bf401c3b69d8ad69ff254994ce02)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260731188447/en/\n(https://www.businesswire.com/news/home/20260731188447/en/)\n\nMedia Relations: \n\nChet Murray\n\n(781) 462-5126\n\nchet.murray@revvity.com \n(mailto:chet.murray@revvity.com) \n\n\nInvestor Relations: \n\nSteve Willoughby\n\nsteve.willoughby@revvity.com (mailto:steve.willoughby@revvity.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw13WTnya","title":"Revvity Board Declares Quarterly Dividend","author":"Business Wire","ticker":"RVTY","created":"2026-07-31T20:05:00.194Z","tickers":["RVTY"],"exchange":"NYSE","article_body":"Revvity Board Declares Quarterly Dividend\n\nThe Board of Directors of Revvity, Inc.\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.revvity.com%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Revvity%2C+Inc.&index=1&md5=fe0d6c75dfcd2999a171b009d1893cf1)\n(NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share\nof common stock. This dividend is payable on November 13, 2026 to all\nshareholders of record at the close of business on October 23, 2026.\n\nAbout Revvity\n\nAt Revvity, “impossible” is inspiration, and “can’t be done” is a\ncall to action. Revvity provides health science solutions, technologies,\nexpertise and services that deliver complete workflows from discovery to\ndevelopment, and diagnosis to cure. Revvity is revolutionizing what’s\npossible in healthcare, with specialized focus areas in translational\nmulti-omics technologies, biomarker identification, imaging, prediction,\nscreening, detection and diagnosis, informatics and more.\n\nWith 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity\nserves customers across pharmaceutical and biotech, diagnostic labs, academia\nand governments. It is part of the S&P 500 index and has customers in more\nthan 160 countries.\n\nStay updated by following our Newsroom\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnews.revvity.com%2Foverview%2Fdefault.aspx&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Newsroom&index=2&md5=7a20070ef771ef421fa2501cfb6416af)\n, LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Frevvity%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=LinkedIn&index=3&md5=aeec4cf587893654c63524eab42bb246)\n, X\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2FRevvityInc&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=X&index=4&md5=e85a0ef6ec61eb426d884ffd880804fd)\n, YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCUqLrqOpUUwhz3UaLn78tVQ&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=YouTube&index=5&md5=bf0ff09de6e49412084b81abee1d414d)\n, Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FRevvityInc&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Facebook&index=6&md5=6f9e393ecf03b48a979732f8bf837258)\nand Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Frevvity%2F&esheet=54580862&newsitemid=20260731188447&lan=en-US&anchor=Instagram&index=7&md5=e064bf401c3b69d8ad69ff254994ce02)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260731188447/en/\n(https://www.businesswire.com/news/home/20260731188447/en/)\n\nMedia Relations: \n\nChet Murray\n\n(781) 462-5126\n\nchet.murray@revvity.com \n(mailto:chet.murray@revvity.com) \n\n\nInvestor Relations: \n\nSteve Willoughby\n\nsteve.willoughby@revvity.com (mailto:steve.willoughby@revvity.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-07-31T20:05:00.312996081Z","server_sent_at_ms":1785528300312},"received_at":"2026-07-31T20:05:00.364Z","source_url":"https://www.businesswire.com/news/home/20260731188447/en/"},"analysis":{"id":"94443","press_release_id":"105431","analysis_json":{"industry":{"label":"Life Sciences Tools & Services","sector":"Health Care"},"redFlags":[],"eventType":"dividend","narrative":"Revvity's Board of Directors declared a regular quarterly dividend of $0.07 per share of common stock.\n\nThe dividend is payable on November 13, 2026 to shareholders of record at the close of business on October 23, 2026.\n\nThe company reported 2025 revenue of $2.9 billion and serves customers in more than 160 countries as part of the S&P 500 index.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine quarterly dividend of $0.07 declared, payable in November."},"keyFigures":{"revenue":"$2.9 billion","customDimensions":{"dividend_per_share":0.07}},"quotedText":"","namedEntities":{"people":[{"name":"Chet Murray","role":"Media Relations"},{"name":"Steve Willoughby","role":"Investor Relations"}],"products":[],"companies":[{"name":"Revvity, Inc.","ticker":"RVTY"}],"dollarAmounts":[{"amount":"$0.07","context":"regular quarterly dividend per share"},{"amount":"$2.9 billion","context":"2025 revenue"}]},"materialImpact":{"score":2,"reasoning":"Routine declaration of a regular quarterly dividend. While shareholder-friendly, it is a standard corporate action for an established S&P 500 constituent with no change to policy indicated."},"tickerRelevance":{"others":[],"primary":"RVTY"},"globalImportance":15,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"S&P_500","eventGravity":"routine_dividend"}},"event_type":"dividend","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Revvity's Board of Directors declared a regular quarterly dividend of $0.07 per share of common stock.\n\nThe dividend is payable on November 13, 2026 to shareholders of record at the close of business on October 23, 2026.\n\nThe company reported 2025 revenue of $2.9 billion and serves customers in more than 160 countries as part of the S&P 500 index.","key_figures":{"revenue":"$2.9 billion","customDimensions":{"dividend_per_share":0.07}},"named_entities":{"people":[{"name":"Chet Murray","role":"Media Relations"},{"name":"Steve Willoughby","role":"Investor Relations"}],"products":[],"companies":[{"name":"Revvity, Inc.","ticker":"RVTY"}],"dollarAmounts":[{"amount":"$0.07","context":"regular quarterly dividend per share"},{"amount":"$2.9 billion","context":"2025 revenue"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-31T20:11:16.696Z","global_importance":15,"audience_relevance":20,"importance_components":{"tickerTier":"S&P_500","eventGravity":"routine_dividend"}},"durationMs":157900,"modelName":"glm-4.7"}}